ArticleMicrobial cell factories2026
Biosynthesis mechanisms, antimicrobial effects, and characterization of silver nanoparticles produced by bacterial and actinomycete isolates derived from a gold mine.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundSilver nanoparticles (AgNPs) are widely studied for their antimicrobial properties, and microbial synthesis offers an eco-friendly and scalable alternative to conventional methods. While Streptomyces spp. are well-known producers, little is known about AgNP biosynthesis by microorganisms adapted to metal-rich environments such as gold mines, which may represent a largely unexplored source of microorganisms with potential for AgNP biosynthesis. This study investigated the biosynthetic potential of bacterial and actinomycete isolates recovered from the Sukari Gold Mine, Egypt, with a focus on optimizing cell-free extract (CFE) preparation, nanoparticle characterization, and understanding the underlying biochemical contributions.
resultsOut of 57 isolates, three Streptomyces strains showed the highest AgNP biosynthesis capability. Among the tested methods, soaking was selected as the preferred CFE preparation approach because it provided comparable AgNP biosynthesis while offering a simpler and more practical procedure than freeze/thaw and sonication. The biosynthesized AgNPs exhibited antimicrobial activity against tested microorganisms, with enhanced performance relative to commercial AgNPs. Antimicrobial assessment was supported by MIC and MBC determinations. Biochemical analysis of the CFE revealed the presence of phenols, proteins, and nucleic acids (DNA and RNA), while FTIR analysis identified functional groups including hydroxyl, amine, aromatic, alkene, and alkyne groups, suggesting their involvement in reduction and stabilization processes. The napA gene was detected in all active strains, indicating the potential for nitrate reductase production; however, its role in Ag⁺ reduction appears to be contributory rather than definitive. Characterization using UV-Vis spectroscopy, XRD, FTIR, AFM, HR-TEM, and zeta potential analysis confirmed the formation of stable AgNPs with spherical to irregular morphologies, sizes ranging from 5 to 52 nm, and high colloidal stability (zeta potential up to - 37.3 mV).
conclusionsThese findings highlight gold mine-derived actinomycetes as promising candidates for the green synthesis of stable, bioactive AgNPs and suggest that multiple biomolecules act synergistically during nanoparticle formation.
Indexed as
Identifiers
42823729What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.